EUVIMED · CrossrefJournal
Nature Reviews Cancer
ISSN 1474-175X · Springer Science and Business Media LLC
Latest articles
Flexible strategy for purine supply in tumours
The antioxidant addiction of cancer
Beyond the tumour: circulating extracellular matrix fragments as next-generation cancer biomarkers
3D models to capture and perturb tumour heterogeneity in vitro
Origins and heterogeneity of colorectal cancer
Astrocytes drive stroke-induced glioma progression
Brain barriers at the crossroads of glioma immune surveillance and immunotherapy response
Epigenetic changes linked to cell replication connect ageing with cancer risk
3D multi-omics tumour atlases: from technology to biology and clinical translation
Igniting antitumour immunity with cancer cell pyroptosis
Beyond oncogenesis: the unexplored benefits of viruses in cancer immunity
The DNA damage response and cancer immunotherapy
Stem cells as an essential mediator of the exercise–tumorigenesis link
Regulation of immune checkpoint molecules in cancer immune evasion and therapy
Beyond sex determination: the Y chromosome in male cancers
Mesenchymal stromal/stem cells in tumour initiation, progression and therapy
Structural variants disrupt chromatin architecture
Detection of cytokine-responsive cells using CyCLoPs
PRISM enables accurate microbial discovery in cancer genomics
Serving sulfur to boost anti-tumour immunity
Escaping the trap
Advancing AI for multi-omics and clinical data integration in basic and translational cancer research
The sleeping threat: targeting cancer dormancy to transform metastasis therapy
Context-dependent synthetic lethality — an emerging precision therapeutic approach
Message in a vesicle: T cells boost tumour immunity
Beat it!
An adenosine derivative for the treatment of hepatocellular carcinoma
AACR 2026
Striking the right balance with type I interferon signalling in cancer
Rethinking ovarian cancer III: the past decade and future directions
EUVIMED